Schedule 13G ownership disclosure

Viridian Therapeutics Inc

Security class unavailable · CUSIP: 92790C104

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-119339
Form type
SC 13G/A
Filer
Venrock Healthcare Capital Partners III, L.P.
CIK
CIK 1738048
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub